抗氧化剂线素通过调节AR-NLRP3通路来抑制良性前列腺增生症
Bo-Ram Jin1, Chae-Young Lim2, Hyo-Jung Kim1
1Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea.
Redox biology
|July 16, 2023
概括
米托金 (MitoQ) 通过抑制雄激素受体 (AR) 和NLRP3信号通路,有效治疗良性前列腺增生 (BPH). 这种针对线粒体的抗氧化剂减少了BPH模型中的前列腺细胞增殖和氧化应激.
科学领域:
- 线粒体医学是指线粒体医学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 分子生物学分子生物学
背景情况:
- 米托金 (MitoQ) 是一种针对线粒体的抗氧化剂,具有治疗应用.
- 良性前列腺增生 (BPH) 是一种常见的疾病,其特征是前列腺扩大.
- 了解BPH的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 在BPH模型中研究MitoQ的治疗效果.
- 阐明MitoQ在BPH中的作用的潜在分子机制.
- 为了确定MitoQ是否抑制雄激素受体 (AR) 和NLRP3炎症体信号传递.
主要方法:
- 在体外研究中,使用用二铁 (DHT) 治疗的前列腺上皮细胞.
- 分子建模用于预测DHT,AR,NLRP3和MitoQ之间的相互作用.
- 通过siRNA介导的AR和NLRP3.3的淘汰.
- 在体内研究使用与MitoQ治疗的BPH大鼠模型.
主要成果:
- MitoQ抑制了DHT诱导的细胞增殖和线粒体反应性氧物种 (ROS) 生产.
- 分子建模表明,MitoQ可以抑制AR和NLRP3.
- siRNA实验证实了AR,NLRP3和MitoQ的影响之间的联系.
- 通过抑制AR和NLRP3信号传递,MitoQ给药减少了BPH大鼠的前列腺大小和炎症.
结论:
- MitoQ 作为NLRP3炎症酶和雄激素受体 (AR) 信号传递的抑制剂.
- MitoQ在治疗良性前列腺增生症 (BPH) 中显示出显著的治疗潜力.
- 通过抑制AR和NLRP3通路,MitoQ的抗氧化和抗增殖作用通过抑制AR和NLRP3通路进行中介.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
The Electron Transport Chain
17.0K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.0K
Antihypertensive Drugs: Vasodilators
573
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
573
Oxidation of Phenols to Quinones
3.2K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


